Hunter Capital RTO 1 extends ResoTher Pharma deal talks to Dec. 31, 2026
Hunter Capital RTO 1 has extended its non-binding letter of intent with ResoTher Pharma for a planned reverse acquisition transaction.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.